???pagination.result.count???
The cytoskeletal effector xPAK1 is expressed during both ear and lateral line development in Xenopus. , Islam N , Poitras L, Moss T ., Int J Dev Biol. February 1, 2000; 44 (2): 245-8.
Induction of oocyte maturation by jun-N-terminal kinase ( JNK) on the oncogenic ras- p21 pathway is dependent on the raf-MEK signal transduction pathway. , Chie L, Amar S, Kung HF, Lin MC, Chen H , Chung DL, Adler V, Ronai Z, Friedman FK, Robinson RC, Kovac C, Brandt-Rauf PW, Yamaizumi Z, Michl J, Pincus MR., Cancer Chemother Pharmacol. January 1, 2000; 45 (6): 441-9.
Glutathione-S-Transferase as a selective inhibitor of oncogenic ras- p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase. , Villafania A, Anwar K, Amar S, Chie L, Way D, Chung DL, Adler V, Ronai Z, Brandt-Rauf PW, Yamaizumii Z, Kung HF, Pincus MR., Ann Clin Lab Sci. January 1, 2000; 30 (1): 57-64.
Cell swelling activates stress-activated protein kinases, p38 MAP kinase and JNK, in renal epithelial A6 cells. , Niisato N, Post M, Van Driessche W, Marunaka Y., Biochem Biophys Res Commun. December 20, 1999; 266 (2): 547-50.
Concentration-dependent positive and negative regulation of a MAP kinase by a MAP kinase kinase. , Kieran MW, Katz S, Vail B, Zon LI , Mayer BJ., Oncogene. November 18, 1999; 18 (48): 6647-57.
Distinct domains of mouse dishevelled are responsible for the c- Jun N-terminal kinase/stress-activated protein kinase activation and the axis formation in vertebrates. , Moriguchi T, Kawachi K, Kamakura S, Masuyama N, Yamanaka H , Matsumoto K , Kikuchi A, Nishida E ., J Biol Chem. October 22, 1999; 274 (43): 30957-62.
Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , Jacobs D, Glossip D, Xing H, Muslin AJ, Kornfeld K., Genes Dev. January 15, 1999; 13 (2): 163-75.
Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. , Takenaka K, Moriguchi T, Nishida E ., Science. April 24, 1998; 280 (5363): 599-602.
Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 ( MKK6); comparison of its substrate specificity with that of other SAP kinases. , Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P., EMBO J. June 16, 1997; 16 (12): 3563-71.
Activation of stress-activated protein kinase-3 ( SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 ( MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/ p38). , Cuenda A, Cohen P, Buée-Scherrer V, Goedert M., EMBO J. January 15, 1997; 16 (2): 295-305.
Selective inhibition of oncogenic ras- p21 in vivo by agents that block its interaction with jun-N-kinase ( JNK) and jun proteins. Implications for the design of selective chemotherapeutic agents. , Amar S, Glozman A, Chung D, Adler V, Ronai Z, Friedman FK, Robinson R, Brandt-Rauf P, Yamaizumi Z, Pincus MR., Cancer Chemother Pharmacol. January 1, 1997; 41 (1): 79-85.
Differential regulation of the MAP, SAP and RK/ p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. , Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM., EMBO J. July 15, 1996; 15 (14): 3621-32.
Activation of mitogen-activated protein kinase cascades by p21-activated protein kinases in cell-free extracts of Xenopus oocytes. , Polverino A, Frost J, Yang P, Hutchison M, Neiman AM, Cobb MH, Marcus S., J Biol Chem. November 3, 1995; 270 (44): 26067-70.